-- MediSwitch Drug Interactions Import (Part 90/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6894, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6894, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(6894, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(6894, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6894, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6894, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6894, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(6894, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6894, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(6894, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(6894, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(6894, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6894, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23766, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(23766, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(23766, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(23766, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23766, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23766, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(23766, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(23766, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23766, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23766, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23766, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(23766, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23766, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(23766, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(23766, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(23766, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(23766, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23766, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(24366, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(24366, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(24366, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(24366, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(24366, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(24366, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(24366, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(24366, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(24366, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(24366, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(24366, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(24366, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(24366, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(24366, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(24366, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(24366, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(24366, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(24366, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6450, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(6450, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6450, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6450, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6450, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6450, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(6450, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(6450, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6450, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6450, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6450, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(6450, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6450, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(6450, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(6450, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(6450, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6450, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32213, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(32213, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(32213, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(32213, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32213, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32213, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(32213, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(32213, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32213, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32213, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32213, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(32213, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32213, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(32213, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(32213, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(32213, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32213, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(11570, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(11570, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(11570, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(11570, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(11570, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(11570, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(11570, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(11570, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(11570, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(11570, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(11570, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(11570, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5828, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(5828, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(5828, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(5828, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5828, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5828, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(5828, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(5828, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5828, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5828, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5828, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(5828, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5828, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(5828, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(5828, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(5828, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5828, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32010, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(32010, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32010, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32010, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(32010, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32010, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32010, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(32010, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32010, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(32010, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(32010, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(32010, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6725, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(6725, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6725, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6725, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6725, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6725, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(6725, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(6725, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6725, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6725, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6725, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(6725, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6725, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(6725, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(6725, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(6725, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6725, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(10197, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(10197, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(10197, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(10197, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(10197, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(10197, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(10197, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(10197, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(10197, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(10197, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(10197, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(10197, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20828, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(20828, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(20828, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(20828, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20828, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20828, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(20828, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(20828, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(20828, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(20828, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20828, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(20828, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20828, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(20828, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(20828, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(20828, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(20828, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(20828, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5027, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(5027, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(5027, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(5027, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5027, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5027, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(5027, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(5027, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5027, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5027, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5027, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(5027, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(5027, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(5027, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(5027, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(5027, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(5027, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6135, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(6135, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6135, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(6135, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6135, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6135, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(6135, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(6135, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6135, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6135, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6135, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(6135, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6135, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(6135, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(6135, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(6135, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(6135, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6135, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7202, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(7202, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(7202, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(7202, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7202, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7202, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(7202, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(7202, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7202, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7202, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7202, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(7202, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7202, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(7202, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(7202, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(7202, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7202, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(31941, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(31941, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(31941, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(31941, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(31941, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(31941, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(31941, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(31941, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(31941, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(31941, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(31941, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(31941, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(31941, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(31941, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(31941, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(31941, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(4811, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(4811, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(4811, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(4811, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(4811, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(4811, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(4811, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(4811, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(4811, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(4811, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(4811, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(22685, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(22685, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(22685, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(22685, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(22685, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(22685, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(22685, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(22685, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(22685, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(22685, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(22685, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(22685, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32596, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(32596, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(32596, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(32596, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32596, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32596, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(32596, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(32596, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32596, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32596, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32596, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(32596, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(32596, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(32596, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(32596, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(32596, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(32596, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(13376, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(13376, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(13376, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(13376, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(13376, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(13376, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(13376, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(13376, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(13376, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(13376, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(13376, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20966, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(20966, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20966, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20966, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(20966, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(20966, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20966, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(20966, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20966, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(20966, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20966, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3579, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(3579, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3579, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3579, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(3579, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(3579, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3579, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(3579, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3579, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(3579, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(3579, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33529, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(33529, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(33529, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(33529, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33529, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33529, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(33529, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(33529, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33529, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33529, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33529, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(33529, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33529, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(33529, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(33529, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33529, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7843, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(7843, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(7843, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(7843, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7843, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7843, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(7843, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(7843, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7843, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7843, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7843, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(7843, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(7843, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(7843, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(7843, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(7843, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19345, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(19345, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(19345, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(19345, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19345, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19345, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(19345, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(19345, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(19345, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(19345, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19345, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(19345, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19345, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(19345, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(19345, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(19345, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(19345, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6359, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(6359, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6359, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6359, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(6359, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(6359, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6359, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(6359, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(6359, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(6359, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(6359, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(28889, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(28889, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(28889, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(28889, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(28889, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(28889, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(28889, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(28889, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(28889, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(28889, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(28889, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3888, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(3888, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(3888, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(3888, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3888, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3888, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(3888, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(3888, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(3888, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(3888, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3888, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(3888, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(3888, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(3888, 'trientine tetrahydrochloride', 'N/A', 'minor', '(2.2, 7.1) 7.1 Mineral Supplements and Other Oral Drugs CUVRIOR has the potential to chelate non-copper cations in mineral supplements and other oral drugs, and could be rendered ineffective prior to systemic absorption.', 'DailyMed'),
(3888, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(3888, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(3888, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3888, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20501, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(20501, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20501, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20501, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(20501, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(20501, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20501, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(20501, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(20501, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(20501, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(20501, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(20501, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(17174, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(17174, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(17174, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(17174, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(17174, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(17174, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(17174, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(17174, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(17174, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(17174, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(17174, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(17174, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(17174, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(17174, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(17174, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(17174, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(27311, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(27311, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(27311, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(27311, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(27311, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(27311, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(27311, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(27311, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(27311, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(27311, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(27311, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33809, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(33809, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33809, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33809, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(33809, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33809, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33809, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(33809, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33809, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(33809, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(33809, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(33809, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33131, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(33131, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(33131, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(33131, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33131, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33131, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(33131, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(33131, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33131, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33131, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33131, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(33131, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(33131, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(33131, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(33131, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(33131, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23150, 'cefuroxime axetil', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict''s or Fehling''s solution), but not with enzyme-based tests for glycosuria.', 'DailyMed'),
(23150, 'trientine hydrochloride', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(23150, 'trientine', 'N/A', 'minor', 'However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.', 'DailyMed'),
(23150, 'piperacillin and tazobactam', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23150, 'tazobactam sodium and piperacillin sodium', 'N/A', 'minor', 'As with other penicillins, the administration of ZOSYN may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23150, 'cupric chloride', 'N/A', 'minor', 'Alternatively, the multivitamin additive may be added to one container of TPN solution, followed by copper in a subsequent container.', 'DailyMed'),
(23150, 'omeprazole, clarithromycin, amoxicillin', 'N/A', 'minor', '7.16 Drug-Laboratory Test Interactions High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in urine.', 'DailyMed'),
(23150, 'nitrofurantoin', 'N/A', 'minor', '7.3 Drug Interference with Laboratory Tests The presence of nitrofurantoin can cause a false-positive reaction for glucose in the urine when using Benedict''s or Fehling''s copper reduction reaction to determine the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23150, 'omeprazole magnesium, amoxicillin and rifabutin', 'N/A', 'minor', 'Urine Glucose Test Clinical Impact High urine concentrations of ampicillin or amoxicillin may result in false-positive reactions when using glucose tests based on the Benedict’s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23150, 'piperacillin sodium and tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23150, 'piperacillin sodium,tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST ®).', 'DailyMed'),
(23150, 'piperacillin sodium, tazobactam sodium', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam for injection may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(23150, 'copper cu 64 dotatate', 'N/A', 'minor', '7 DRUG INTERACTIONS Somatostatin Analogs: Somatostatin analogs competitively bind to the same somatostatin receptors as copper Cu 64 dotatate and may affect imaging. ( 2.3, 7.1) 7.1 Somatostatin Analogs Non-radioactive somatostatin analogs and copper Cu 64 dotatate competitively bind to somatostatin receptors (SSTR2).', 'DailyMed'),
(23150, 'sulopenem etzadroxil and probenecid', 'N/A', 'moderate', 'If concomitant use with ORLYNVAH is necessary, monitor more frequently for adverse reactions associated with ORLYNVAH (e.g., diarrhea and nausea) [see Adverse Reactions ( 6.1 )] 7.3 Drug/Laboratory Interactions Treatment with ORLYNVAH may interfere with copper sulfate urine glucose tests, resulting in false-positive readings for glycosuria.', 'DailyMed'),
(23150, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug-drug interaction or drug-herbal supplement interaction studies have been conducted with Paragard.', 'DailyMed'),
(23150, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine. High urine concentrations of ampicillin or amoxicillin may cause false-positive results when using glucose tests based on the Benedict''s copper reduction reaction that determines the amount of reducing substances like glucose in the urine.', 'DailyMed'),
(23150, 'piperacillin and tazobactam and sodium chloride', 'N/A', 'minor', 'As with other penicillins, the administration of piperacillin and tazobactam may result in a false-positive reaction for glucose in the urine using a copper-reduction method (CLINITEST®).', 'DailyMed'),
(19136, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(3196, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19142, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19149, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(16968, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(17330, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(3201, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19141, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(11410, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(4955, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19140, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(14799, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(23278, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(4958, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(28299, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3202, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19137, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(6648, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19138, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(26046, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(30101, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19139, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(19144, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(13007, 'drug_class', 'N/A', 'major', 'Drug interactions Fluticasone propionate is a substrate of cytochrome P450 3A4. A drug interaction study with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations (see CLINICAL PHARMACOLOGY: Drug Interactions). During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing syndrome and adrenal suppression. Therefore, coadministration of fluticasone propionate and ritonavir is not recommended unless the potential benefit to the ', 'DailyMed'),
(14108, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Enter section text here • Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1, 14.1).• Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2). 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the coadministration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or Ndesmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation. This treatment arm wa', 'DailyMed'),
(14107, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Enter section text here • Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1, 14.1).• Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2). 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the coadministration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or Ndesmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation. This treatment arm wa', 'DailyMed'),
(14391, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Enter section text here • Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1, 14.1).• Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2). 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the coadministration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or Ndesmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation. This treatment arm wa', 'DailyMed'),
(14109, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Enter section text here • Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1, 14.1).• Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2). 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the coadministration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or Ndesmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation. This treatment arm wa', 'DailyMed'),
(5345, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Enter section text here • Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1, 14.1).• Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2). 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the coadministration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or Ndesmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation. This treatment arm wa', 'DailyMed'),
(27326, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28577, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28576, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(11734, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(27356, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28578, 'metformin', 'N/A', 'minor', '(7.2) Concomitant use with metformin immediate release tablets reduced exposure and peak concentration of trospium. 7.4 Metformin Co-administration of 500 mg metformin immediate release tablets twice daily with trospium chloride 60 mg extended release reduced the steady-state systemic exposure of trospium by approximately 29% for mean AUC0-24 and by 34% for mean Cmax [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(15894, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(13179, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(33856, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(23020, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(15600, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(2317, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(19321, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(31682, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(19579, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(21371, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(3696, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(20810, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(10879, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(32281, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(30022, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(24365, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(23761, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(2962, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(2446, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(14765, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(1302, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(15741, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(31848, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(27771, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(2558, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(21157, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(17015, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(26034, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(13203, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(19107, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(3139, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(3680, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(13712, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(2619, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(1591, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(28807, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(6637, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(1602, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(202, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(4216, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(28679, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(31474, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(9234, 'drug_class', 'N/A', 'moderate', '7. DRUG INTERACTIONS ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​ Ascorbic acid may cause acidification of the urine and result in decreased amphetamine serum levels affect excretion and plasma concentrations of other drugs sensitive to urine pH (7.2). ​Warfarin:​ Continue standard monitoring (7.3) ​ See 17 for PATIENT COUNSELING INFORMATION ​Antibiotics:​ Ascorbic acid may decrease the activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. Bleomycin is inactivated ​in vitro ​by ascorbic acid (7.1). ​Amphetamine and Other Drugs Affected by Urine Acidification:​', 'DailyMed'),
(26065, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS Consider alternative therapies that are not CYP1A2 inducers or inhibitors during treatment with TREANDA. (7) 7.1 Effect of Other Drugs on TREANDA CYP1A2 Inhibitors The coadministration of TREANDA with CYP1A2 inhibitors may increase bendamustine plasma concentrations and may result in increased incidence of adverse reactions with TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inhibitors during treatment with TREANDA. CYP1A2 Inducers The coadministration of TREANDA with CYP1A2 inducers may decrease bendamustine plasma concentrations and may result in decreased efficacy of TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inducers during treatment with TREANDA.', 'DailyMed'),
(15061, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS Consider alternative therapies that are not CYP1A2 inducers or inhibitors during treatment with TREANDA. (7) 7.1 Effect of Other Drugs on TREANDA CYP1A2 Inhibitors The coadministration of TREANDA with CYP1A2 inhibitors may increase bendamustine plasma concentrations and may result in increased incidence of adverse reactions with TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inhibitors during treatment with TREANDA. CYP1A2 Inducers The coadministration of TREANDA with CYP1A2 inducers may decrease bendamustine plasma concentrations and may result in decreased efficacy of TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inducers during treatment with TREANDA.', 'DailyMed'),
(26066, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS Consider alternative therapies that are not CYP1A2 inducers or inhibitors during treatment with TREANDA. (7) 7.1 Effect of Other Drugs on TREANDA CYP1A2 Inhibitors The coadministration of TREANDA with CYP1A2 inhibitors may increase bendamustine plasma concentrations and may result in increased incidence of adverse reactions with TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inhibitors during treatment with TREANDA. CYP1A2 Inducers The coadministration of TREANDA with CYP1A2 inducers may decrease bendamustine plasma concentrations and may result in decreased efficacy of TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inducers during treatment with TREANDA.', 'DailyMed'),
(15060, 'drug_class', 'N/A', 'minor', '7 DRUG INTERACTIONS Consider alternative therapies that are not CYP1A2 inducers or inhibitors during treatment with TREANDA. (7) 7.1 Effect of Other Drugs on TREANDA CYP1A2 Inhibitors The coadministration of TREANDA with CYP1A2 inhibitors may increase bendamustine plasma concentrations and may result in increased incidence of adverse reactions with TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inhibitors during treatment with TREANDA. CYP1A2 Inducers The coadministration of TREANDA with CYP1A2 inducers may decrease bendamustine plasma concentrations and may result in decreased efficacy of TREANDA [see Clinical Pharmacology (12.3)]. Consider alternative therapies that are not CYP1A2 inducers during treatment with TREANDA.', 'DailyMed'),
(10188, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎7). Cyclosporine: may have decreased bioavailability and require dose adjustment (7). Insulin and Antidiabetic Drugs: patients receiving insulin or antidiabetic drugs agents may require dose adjustment (‎7). Digoxin: exposure may be decreased and assessment of clinical response to digoxin should be performed (‎7). Lisinopril: bioavailability may be increased, monitor patient''s blood pressure and adjust dose of lisinopril if needed (‎7). Levonorgestrel: counsel women to use an alternative non-hormonal method of contraception or a back-up method when MYCAPSSA is used with combined oral contraceptives (‎7). Bromocriptine: d', 'DailyMed'),
(15062, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎7). Cyclosporine: may have decreased bioavailability and require dose adjustment (7). Insulin and Antidiabetic Drugs: patients receiving insulin or antidiabetic drugs agents may require dose adjustment (‎7). Digoxin: exposure may be decreased and assessment of clinical response to digoxin should be performed (‎7). Lisinopril: bioavailability may be increased, monitor patient''s blood pressure and adjust dose of lisinopril if needed (‎7). Levonorgestrel: counsel women to use an alternative non-hormonal method of contraception or a back-up method when MYCAPSSA is used with combined oral contraceptives (‎7). Bromocriptine: d', 'DailyMed'),
(26499, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎7). Cyclosporine: may have decreased bioavailability and require dose adjustment (7). Insulin and Antidiabetic Drugs: patients receiving insulin or antidiabetic drugs agents may require dose adjustment (‎7). Digoxin: exposure may be decreased and assessment of clinical response to digoxin should be performed (‎7). Lisinopril: bioavailability may be increased, monitor patient''s blood pressure and adjust dose of lisinopril if needed (‎7). Levonorgestrel: counsel women to use an alternative non-hormonal method of contraception or a back-up method when MYCAPSSA is used with combined oral contraceptives (‎7). Bromocriptine: d', 'DailyMed'),
(12372, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎7). Cyclosporine: may have decreased bioavailability and require dose adjustment (7). Insulin and Antidiabetic Drugs: patients receiving insulin or antidiabetic drugs agents may require dose adjustment (‎7). Digoxin: exposure may be decreased and assessment of clinical response to digoxin should be performed (‎7). Lisinopril: bioavailability may be increased, monitor patient''s blood pressure and adjust dose of lisinopril if needed (‎7). Levonorgestrel: counsel women to use an alternative non-hormonal method of contraception or a back-up method when MYCAPSSA is used with combined oral contraceptives (‎7). Bromocriptine: d', 'DailyMed'),
(15063, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎7). Cyclosporine: may have decreased bioavailability and require dose adjustment (7). Insulin and Antidiabetic Drugs: patients receiving insulin or antidiabetic drugs agents may require dose adjustment (‎7). Digoxin: exposure may be decreased and assessment of clinical response to digoxin should be performed (‎7). Lisinopril: bioavailability may be increased, monitor patient''s blood pressure and adjust dose of lisinopril if needed (‎7). Levonorgestrel: counsel women to use an alternative non-hormonal method of contraception or a back-up method when MYCAPSSA is used with combined oral contraceptives (‎7). Bromocriptine: d', 'DailyMed'),
(3130, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3130, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3130, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3130, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3130, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3130, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3224, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3224, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3224, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3224, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24892, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24892, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24892, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24892, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24892, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24892, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11157, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11157, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11157, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2840, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2840, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2840, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2840, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28620, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28620, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28620, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28620, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28620, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28620, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5046, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5046, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5046, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5046, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5046, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5046, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5046, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5046, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(18342, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18342, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18342, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18342, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18342, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18342, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18342, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18342, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29008, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29008, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29008, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29008, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29008, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29008, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8301, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8301, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8301, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25056, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25056, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25056, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25056, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25056, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25056, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(14110, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14110, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14110, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14110, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31541, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31541, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31541, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31541, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3227, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3227, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3227, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3227, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24891, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24891, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24891, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24891, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24891, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18330, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18330, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18330, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18330, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18330, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18330, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(9373, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9373, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9373, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9373, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9373, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9373, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7389, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7389, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7389, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7389, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29364, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29364, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29364, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29364, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29364, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29364, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(9606, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9606, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9606, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9606, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9606, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9606, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9606, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9606, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2080, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2080, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(2080, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2080, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2080, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(2080, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31942, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31942, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31942, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31942, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12955, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12955, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12955, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12955, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12955, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12955, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12955, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12955, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(16256, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(16256, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(16256, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16256, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16256, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(16256, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16256, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16256, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(21418, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21418, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(21418, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(21418, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21418, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(21418, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(25422, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25422, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25422, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25422, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25422, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25422, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25422, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25422, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(16881, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16881, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16881, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(16881, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16881, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16881, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(9605, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9605, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9605, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9605, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9605, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9605, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9605, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9605, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2829, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2829, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2829, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1349, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1349, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1349, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1349, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1349, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1349, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(14962, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14962, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14962, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14962, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14962, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14962, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29491, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29491, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29491, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29491, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29491, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29491, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29491, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29491, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30584, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30584, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30584, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14974, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14974, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14974, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14974, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14974, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14974, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11830, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11830, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11830, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11830, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11830, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11830, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33324, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33324, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33324, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33324, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33324, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33324, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5181, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5181, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5181, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5181, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5181, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5181, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5181, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5181, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7747, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7747, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7747, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7747, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7747, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7747, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7747, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7747, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28277, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28277, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28277, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28277, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28277, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28277, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3516, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3516, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(3516, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32200, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(32200, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32200, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(23932, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(23932, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(23932, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(25451, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(25451, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(25451, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31333, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(31333, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31333, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(821, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(821, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(821, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13642, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(13642, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13642, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31505, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(31505, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31505, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6570, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(6570, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6570, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(16643, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(16643, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(16643, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31123, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(31123, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(31123, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(2371, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(2371, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(2371, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(5779, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(5779, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(5779, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(10302, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(10302, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(10302, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13882, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(13882, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13882, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(5309, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(5309, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(5309, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1926, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(1926, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1926, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13289, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(13289, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(13289, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6029, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(6029, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6029, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1471, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(1471, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1471, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32329, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(32329, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32329, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(26728, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(26728, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(26728, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6106, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(6106, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6106, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6067, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(6067, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(6067, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1703, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(1703, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(1703, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(7922, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(7922, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(7922, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(26727, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(26727, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(26727, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(16216, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(16216, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(16216, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32233, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(32233, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(32233, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(10301, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(10301, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(10301, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(3888, 'baloxavir marboxil', 'N/A', 'minor', '7 DRUG INTERACTIONS Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc).', 'DailyMed'),
(3888, 'eltrombopag olamine', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(3888, 'eltrombopag', 'N/A', 'minor', '7 DRUG INTERACTIONS 7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids.', 'DailyMed'),
(8165, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(24561, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(24572, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(8169, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25261, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25001, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(8097, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25000, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20775, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(22665, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(8168, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(4884, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(7826, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25259, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(7827, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(7824, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(2797, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25262, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(29583, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(516, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(7828, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(7825, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25002, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(12571, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(29582, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(27683, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(25257, 'drug_class', 'N/A', 'minor', 'Drug Interactions: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics or tranquilizers. The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxidase inhibitors. Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). Gastroparesis (gastric stasis) may be responsible for poor diabetic cont', 'DailyMed'),
(15480, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Toremifene: Recovery could be delayed in patients using toremifene. ( 7.2) Hormonal contraceptives: Patients using hormonal contraceptives must use an additional, non-hormonal method of contraception for the next 7 days following BRIDION administration. ( 5.6, 7.3) 7.1 Summary The information reported in sections 7.2 – 7.4 is based on binding affinity between BRIDION and other drugs, preclinical experiments, clinical studies and simulations of a pharmacokinetic-pharmacodynamic (PK-PD) model. Based on these considerations, no clinically significant pharmacodynamic interactions with other drugs are expected, with the exception of toremifene and hormonal contraceptives. 7.2 Interactions Potentially Affecting the Efficacy of BRIDION Toremifene For toremifene, which has a re', 'DailyMed'),
(27084, 'venlafaxine', 'N/A', 'major', 'Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon of venlafaxine. In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.', 'DailyMed'),
(10558, 'venlafaxine', 'N/A', 'major', 'Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon of venlafaxine. In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.', 'DailyMed'),
(27083, 'venlafaxine', 'N/A', 'major', 'Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon of venlafaxine. In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.', 'DailyMed'),
(29828, 'venlafaxine', 'N/A', 'major', 'Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon of venlafaxine. In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.', 'DailyMed'),
(26927, 'venlafaxine', 'N/A', 'major', 'Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon of venlafaxine. In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.', 'DailyMed'),
(30532, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(30532, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(30532, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13291, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(13291, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(13291, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(17984, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(17984, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(17984, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(13292, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(13292, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(13292, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(17982, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(17982, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(17982, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(4802, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(4802, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(4802, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18955, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(18955, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(18955, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(17985, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(17985, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(17985, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(17983, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(17983, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(17983, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18952, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(18952, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(18952, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(17981, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(17981, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(17981, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(18953, 'drug_class', 'N/A', 'contraindicated', 'Drug Interactions Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when fentanyl transdermal system is given concurrently with agents that affect CYP3A4 activity. Coadminstration with agents that induce CYP3A4 activity may reduce the efficacy of fentanyl transdermal system. The concomitant use of transdermal fentanyl with all CYP3A4 inhibitors (such as ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfanivir, nefazadone, amiodarone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, and verapamil) may result in an increase in fentanyl plasma concentrations, which could increase or pro', 'DailyMed'),
(18953, 'tramadol', 'N/A', 'minor', 'Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).', 'DailyMed'),
(18953, 'gabapentin', 'N/A', 'minor', 'Examples: Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, other opioids, alcohol.', 'DailyMed'),
(6652, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26229, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26225, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26227, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(6655, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(21034, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(23441, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(4146, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(21045, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(4128, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(13403, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(23443, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(23442, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(5666, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26637, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(21046, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26226, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(26228, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(4155, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(20986, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(7200, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(4164, 'lh)', 'N/A', 'severe', 'Norethindrone/ethinyl estradiol: In a study of 31 premenopausal female patients with severe recalcitrant nodular acne receiving OrthoNovum® 7/7/7 Tablets as an oral contraceptive agent, Amnesteem at the recommended dose of 1 mg/kg/day, did not induce clinically relevant changes in the pharmacokinetics of ethinyl estradiol and norethindrone and in the serum levels of progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).', 'DailyMed'),
(28566, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18373, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32618, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2216, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(23413, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(9939, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29774, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(6830, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(26235, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2218, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(12709, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(25640, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18370, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(15998, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(17727, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(30293, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(11643, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16065, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32614, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16064, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28563, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(8047, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29773, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(26236, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29771, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(23989, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18327, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(4230, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(21338, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(23986, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(22008, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18371, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(25643, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29602, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(9177, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32615, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(25641, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32617, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29772, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2268, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2287, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16048, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(12640, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28562, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(12639, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(30040, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18372, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(51, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16049, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28564, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(15995, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(21055, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2286, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2220, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2289, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16068, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(15996, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32619, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(23412, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(12641, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29683, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(30038, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(25642, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(22615, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(23988, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2217, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18751, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18328, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(30039, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16047, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(12941, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18369, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(4231, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(29603, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(7503, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(9940, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28462, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18495, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(31806, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(2291, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28470, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(18326, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28463, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(22616, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28565, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(28471, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(32616, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(1860, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(16067, 'drug_class', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible. (7.1) Calcium-containing products: precipitation can occur. (7.2) 7.1 Vancomycin, Amsacrine, Aminoglycosides, and Fluconazole Vancomycin, amsacrine, aminoglycosides, and fluconazole are physically incompatible with ceftriaxone in admixtures [see Dosage and Administration (2.3) ]. 7.2 Calcium-containing Products Precipitation of ceftriaxone-calcium can occur when Ceftriaxone for Injection and Dextrose Injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for Injection and Dextrose Injection must not be administered simultaneously with calcium-containing IV solutions. Ceftriaxone for Injection and Dextrose Injection and calcium-containing sol', 'DailyMed'),
(14575, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(1106, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(18876, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(28379, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(14577, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(14579, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(1102, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(11574, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(28400, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(18877, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(14578, 'drug_class', 'N/A', 'minor', 'Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by atracurium besylate. Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.', 'DailyMed'),
(33768, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(33768, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(33768, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(33768, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2633, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2633, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2633, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2633, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(15492, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(15492, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(15492, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(15492, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20300, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(20300, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20300, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(20300, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2640, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2640, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2640, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2640, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(18192, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(18192, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(18192, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(18192, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2651, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2651, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2651, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2651, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(21255, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(21255, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(21255, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(21255, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(22740, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(22740, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(22740, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(22740, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2650, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2650, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2650, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2650, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(28683, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(28683, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(28683, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(28683, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2642, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2642, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2642, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2642, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(17913, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(17913, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(17913, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(17913, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(1065, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(1065, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(1065, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(1065, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14349, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(14349, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14349, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14349, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(32068, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(32068, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(32068, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(32068, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2628, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2628, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2628, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2628, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2638, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2638, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2638, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2638, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16383, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16383, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16383, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16383, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10378, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(10378, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10378, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(10378, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16402, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16402, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16402, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16402, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20299, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(20299, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20299, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(20299, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2647, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2647, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2647, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2647, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2644, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2644, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2644, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2644, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2624, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2624, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2624, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2624, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2635, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2635, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2635, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2635, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16379, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16379, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16379, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16379, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2631, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2631, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2631, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2631, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2639, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2639, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2639, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2639, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2626, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2626, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2626, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2626, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(30433, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(30433, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(30433, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(30433, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16389, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16389, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16389, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16389, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14876, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(14876, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14876, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14876, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2621, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2621, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2621, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2621, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16363, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16363, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16363, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16363, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16388, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16388, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16388, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16388, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16398, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16398, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16398, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16398, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(4160, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(4160, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(4160, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(4160, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16384, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16384, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16384, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16384, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10379, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(10379, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10379, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(10379, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(17412, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(17412, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(17412, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(17412, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(11908, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(11908, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(11908, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(11908, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16373, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16373, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16373, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16373, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25555, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(25555, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25555, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25555, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2636, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2636, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2636, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2636, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25684, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(25684, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25684, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25684, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14877, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(14877, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(14877, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14877, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(8164, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(8164, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(8164, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(8164, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2590, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2590, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2590, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2590, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16376, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16376, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16376, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16376, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2653, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2653, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2653, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2653, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(13099, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(13099, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(13099, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13099, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2622, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2622, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2622, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2622, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2627, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2627, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2627, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2627, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16367, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16367, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16367, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16367, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2652, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2652, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2652, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2652, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(11448, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(11448, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(11448, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(11448, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2657, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2657, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2657, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2657, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(32071, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(32071, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(32071, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(32071, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2649, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2649, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2649, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2649, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(30017, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(30017, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(30017, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(30017, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16401, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16401, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16401, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16401, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2632, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2632, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2632, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2632, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25055, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(25055, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25055, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25055, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16391, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16391, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16391, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16391, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10377, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(10377, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(10377, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(10377, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(9749, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(9749, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(9749, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(9749, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2630, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2630, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2630, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2630, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(4081, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(4081, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(4081, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(4081, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20298, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(20298, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20298, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(20298, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2654, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2654, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2654, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2654, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(18194, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(18194, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(18194, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(18194, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25682, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(25682, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(25682, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25682, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16399, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16399, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(16399, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(16399, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(26237, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(26237, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(26237, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(26237, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2643, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2643, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(2643, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(2643, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(21429, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(21429, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(21429, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(21429, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20427, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(20427, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(20427, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(20427, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(22588, 'caffeine', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(22588, 'zinc', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(22588, 'salicylic acid', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(22588, 'iron', 'N/A', 'minor', 'Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium/aluminum antacids, sucralfate, Videx® (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, or products containing calcium, iron, or zinc may substantially decrease its absorption, resulting in serum and urine levels considerably lower than desired.', 'DailyMed'),
(33768, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1065, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(8978, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(4160, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(4704, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(18339, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(25437, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(16701, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(11448, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(2969, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(28208, 'drug_class', 'N/A', 'major', '7 DRUG INTERACTIONS Although not specifically identified in studies with tinidazole, the following drug interactions were reported for metronidazole, a chemically-related nitroimidazole. Therefore, these drug interactions may occur with tinidazole. The following drug interactions were reported for metronidazole, a chemically-related nitroimidazole and may therefore occur with tinidazole: Warfarin and other oral coumarin anticoagulants: Anticoagulant dosage may need adjustment during and up to 8 days after tinidazole therapy ( 7.1) Alcohol-containing beverages/preparations: Avoid during and up to 3 days after tinidazole therapy ( 7.1) Lithium: Monitor serum lithium concentrations ( 7.1) Cyclosporine, tacrolimus: Monitor for toxicities of these immunosuppressive drugs ( 7.1) Fluorouracil: Mo', 'DailyMed'),
(4335, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4335, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(4335, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4335, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(4335, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(4335, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(4335, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4335, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(4335, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4335, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4335, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4335, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(4335, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4335, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(4335, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(4335, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(4335, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4335, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(4335, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(4335, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4335, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(4335, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(4335, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(4335, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4335, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4335, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4335, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(4335, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4335, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(4335, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4335, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4335, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(4335, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4335, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(4335, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4335, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4335, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(4335, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4335, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(4335, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4335, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(4335, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(4335, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(4335, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(4335, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4335, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(4335, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4335, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4335, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(4335, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(4335, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(4335, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4335, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4335, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4335, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4335, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(4335, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4335, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4335, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4335, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4335, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(4335, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4335, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4335, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4335, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(4335, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4335, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(4335, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(20642, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20642, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(20642, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20642, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(20642, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(20642, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(20642, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20642, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(20642, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(20642, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20642, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20642, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20642, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(20642, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20642, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(20642, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(20642, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(20642, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(20642, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20642, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(20642, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(20642, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20642, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(20642, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(20642, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(20642, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20642, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20642, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20642, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20642, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(20642, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20642, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(20642, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20642, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20642, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20642, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(20642, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(20642, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20642, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(20642, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20642, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20642, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(20642, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20642, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(20642, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20642, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20642, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(20642, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(20642, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(20642, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(20642, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20642, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(20642, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(20642, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(20642, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(20642, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20642, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20642, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(20642, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(20642, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(20642, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20642, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20642, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20642, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20642, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20642, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20642, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20642, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20642, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20642, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20642, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(20642, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20642, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20642, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20642, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20642, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20642, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20642, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(20642, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(20642, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20642, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(20642, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(20642, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(20642, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(20642, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(20642, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(2976, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2976, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(2976, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2976, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(2976, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(2976, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(2976, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(2976, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(2976, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(2976, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(2976, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(2976, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(2976, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(2976, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(2976, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(2976, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(2976, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(2976, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(2976, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(2976, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(2976, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(2976, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2976, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(2976, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(2976, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(2976, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2976, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(2976, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(2976, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2976, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2976, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2976, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(2976, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(2976, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(2976, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(2976, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(2976, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(2976, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2976, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(2976, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(2976, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(2976, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(2976, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(2976, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(2976, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2976, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(2976, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(2976, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(2976, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(2976, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(2976, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(2976, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(2976, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(2976, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(2976, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(2976, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(2976, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2976, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(2976, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(2976, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(2976, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2976, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2976, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(2976, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(2976, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(2976, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(2976, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2976, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(2976, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2976, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2976, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(2976, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2976, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2976, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(2976, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2976, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2976, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(2976, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(2976, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(2976, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(2976, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(2976, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(2976, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(2976, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(2976, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(2976, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(31006, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31006, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(31006, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31006, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(31006, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(31006, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(31006, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(31006, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(31006, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(31006, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(31006, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(31006, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(31006, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(31006, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(31006, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(31006, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(31006, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(31006, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(31006, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(31006, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31006, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(31006, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(31006, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(31006, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(31006, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(31006, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31006, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(31006, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31006, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(31006, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31006, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(31006, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(31006, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31006, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(31006, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(31006, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(31006, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(31006, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31006, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(31006, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(31006, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(31006, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(31006, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(31006, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(31006, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(31006, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(31006, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(31006, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31006, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(31006, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(31006, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(31006, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31006, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31006, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31006, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(31006, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(31006, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(31006, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31006, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31006, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31006, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(31006, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31006, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(31006, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(31006, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(31006, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(31006, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(31006, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(20946, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20946, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(20946, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20946, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(20946, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(20946, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(20946, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20946, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(20946, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(20946, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20946, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20946, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20946, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(20946, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20946, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(20946, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(20946, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(20946, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(20946, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20946, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(20946, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(20946, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20946, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(20946, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(20946, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(20946, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20946, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20946, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20946, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20946, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(20946, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20946, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(20946, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20946, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20946, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20946, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(20946, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(20946, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20946, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(20946, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20946, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20946, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(20946, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20946, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(20946, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20946, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20946, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(20946, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(20946, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(20946, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(20946, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20946, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(20946, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(20946, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(20946, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(20946, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20946, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20946, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(20946, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(20946, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(20946, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20946, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20946, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20946, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20946, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20946, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20946, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20946, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20946, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20946, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20946, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(20946, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20946, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20946, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20946, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20946, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20946, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20946, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(20946, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(20946, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20946, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(20946, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(20946, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(20946, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(20946, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(20946, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(22336, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22336, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(22336, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22336, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(22336, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(22336, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(22336, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22336, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(22336, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22336, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22336, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(22336, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(22336, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22336, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(22336, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(22336, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(22336, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22336, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(22336, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(22336, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22336, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(22336, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(22336, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(22336, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22336, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22336, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22336, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(22336, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22336, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(22336, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22336, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22336, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(22336, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22336, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(22336, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22336, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(22336, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(22336, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22336, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(22336, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22336, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(22336, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(22336, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(22336, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(22336, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22336, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(22336, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22336, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22336, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(22336, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(22336, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(22336, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22336, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22336, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22336, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22336, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(22336, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22336, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22336, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22336, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22336, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(22336, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22336, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22336, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(22336, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(22336, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(22336, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(22336, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(20647, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20647, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(20647, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20647, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(20647, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(20647, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(20647, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20647, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(20647, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(20647, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20647, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20647, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20647, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(20647, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20647, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(20647, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(20647, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(20647, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(20647, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20647, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(20647, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(20647, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20647, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(20647, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(20647, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(20647, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20647, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20647, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20647, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20647, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(20647, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20647, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(20647, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20647, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20647, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20647, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(20647, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(20647, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20647, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(20647, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20647, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20647, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(20647, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20647, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(20647, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20647, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20647, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(20647, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(20647, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(20647, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(20647, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20647, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(20647, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(20647, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(20647, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(20647, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20647, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20647, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(20647, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(20647, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(20647, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20647, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20647, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20647, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20647, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20647, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20647, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20647, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20647, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20647, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20647, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(20647, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20647, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20647, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20647, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20647, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20647, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20647, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(20647, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(20647, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20647, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(20647, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(20647, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(20647, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(20647, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(20647, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(6335, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(6335, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(6335, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(6335, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(6335, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(6335, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(6335, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(6335, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(6335, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(6335, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(6335, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(6335, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(6335, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(6335, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(6335, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(6335, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(6335, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(6335, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6335, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(6335, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(6335, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(6335, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(6335, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(6335, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(6335, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(6335, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(6335, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(6335, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(6335, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(6335, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(6335, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(6335, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(6335, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(6335, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(6335, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(6335, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(6335, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(6335, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(6335, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(6335, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(6335, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(6335, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(6335, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(6335, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(6335, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(6335, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(6335, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(6335, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(6335, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(6335, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(6335, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(6335, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(6335, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(6335, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(6335, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(6335, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(6335, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(6335, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(6335, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(6335, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(6335, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(6335, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(6335, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(6335, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(6335, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(6335, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(6335, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(6335, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(6335, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(6335, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(6335, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(6335, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(6335, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(6335, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(6335, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(6335, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(6335, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(6335, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(6335, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(6335, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(6335, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(6335, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(6335, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(6335, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(6335, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(6335, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(25199, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(25199, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(25199, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(25199, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(25199, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(25199, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(25199, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(25199, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(25199, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(25199, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(25199, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(25199, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(25199, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(25199, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(25199, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(25199, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(25199, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(25199, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(25199, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(25199, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(25199, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(25199, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(25199, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(25199, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(25199, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(25199, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(25199, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(25199, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(25199, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(25199, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(25199, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(25199, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(25199, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(25199, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(25199, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(25199, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(25199, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(25199, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(25199, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(25199, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(25199, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(25199, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(25199, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(25199, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(25199, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(25199, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(25199, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(25199, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(25199, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(25199, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(25199, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(25199, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(25199, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(25199, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(25199, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(25199, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(25199, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(25199, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(25199, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(25199, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(25199, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(25199, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(25199, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(25199, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(25199, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(25199, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(25199, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(25199, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(25199, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(25199, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(25199, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(25199, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(25199, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(25199, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(25199, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(25199, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(25199, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(25199, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(25199, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(25199, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(25199, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(25199, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(25199, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(25199, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(25199, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(25199, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(31739, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31739, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(31739, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31739, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(31739, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(31739, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(31739, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(31739, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(31739, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(31739, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(31739, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(31739, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(31739, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(31739, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(31739, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(31739, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(31739, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(31739, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(31739, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(31739, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31739, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(31739, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(31739, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(31739, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(31739, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(31739, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31739, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(31739, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31739, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(31739, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31739, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(31739, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(31739, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31739, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31739, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(31739, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(31739, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(31739, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(31739, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(31739, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(31739, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(31739, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(31739, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(31739, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(31739, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(31739, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(31739, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(31739, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31739, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(31739, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(31739, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(31739, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31739, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31739, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(31739, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(31739, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(31739, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(31739, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(31739, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(31739, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31739, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(31739, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(31739, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(31739, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(31739, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(31739, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(31739, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(31739, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(20833, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20833, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(20833, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20833, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(20833, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(20833, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(20833, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20833, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(20833, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(20833, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20833, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20833, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20833, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(20833, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20833, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(20833, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(20833, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(20833, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(20833, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20833, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(20833, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(20833, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20833, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(20833, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(20833, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(20833, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20833, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(20833, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20833, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20833, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(20833, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20833, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(20833, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20833, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20833, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(20833, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(20833, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(20833, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20833, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(20833, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(20833, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(20833, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(20833, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(20833, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(20833, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20833, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20833, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(20833, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(20833, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(20833, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(20833, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(20833, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(20833, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(20833, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(20833, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(20833, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20833, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20833, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(20833, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(20833, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(20833, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20833, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20833, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(20833, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20833, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(20833, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(20833, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(20833, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(20833, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20833, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(20833, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20833, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(20833, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20833, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(20833, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(20833, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20833, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(20833, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20833, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(20833, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(20833, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(20833, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(20833, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(20833, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(20833, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(20833, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(20833, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(27414, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(27414, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(27414, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(27414, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(27414, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(27414, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(27414, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(27414, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(27414, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(27414, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(27414, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(27414, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(27414, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(27414, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(27414, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(27414, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(27414, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(27414, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(27414, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(27414, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(27414, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(27414, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(27414, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(27414, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(27414, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(27414, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(27414, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(27414, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(27414, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(27414, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(27414, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(27414, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(27414, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(27414, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(27414, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(27414, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(27414, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(27414, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(27414, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(27414, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(27414, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(27414, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(27414, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(27414, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(27414, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(27414, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(27414, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(27414, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(27414, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(27414, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(27414, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(27414, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(27414, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(27414, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(27414, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(27414, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(27414, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(27414, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(27414, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(27414, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(27414, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(27414, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(27414, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(27414, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(27414, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(27414, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(27414, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(27414, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27414, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(27414, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(27414, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(27414, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(27414, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(27414, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(27414, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(27414, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(27414, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(27414, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(27414, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(27414, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(27414, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(27414, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(27414, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(27414, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(27414, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(27414, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(14768, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(14768, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(14768, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(14768, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(14768, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(14768, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(14768, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(14768, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(14768, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(14768, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(14768, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(14768, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(14768, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(14768, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(14768, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(14768, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(14768, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(14768, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(14768, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(14768, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14768, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(14768, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(14768, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(14768, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14768, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(14768, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(14768, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(14768, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(14768, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14768, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(14768, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(14768, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(14768, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(14768, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(14768, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(14768, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(14768, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(14768, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(14768, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(14768, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(14768, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14768, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(14768, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(14768, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(14768, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(14768, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(14768, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(14768, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(14768, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(14768, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(14768, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(14768, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(14768, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(14768, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(14768, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(14768, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(14768, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(14768, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(14768, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(14768, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(14768, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(14768, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(14768, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14768, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(14768, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14768, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(14768, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(14768, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(14768, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(14768, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(14768, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(14768, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(14768, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(14768, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(14768, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(14768, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14768, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(14768, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(14768, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(14768, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(14768, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(2076, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2076, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(2076, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2076, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(2076, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(2076, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(2076, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(2076, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(2076, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(2076, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(2076, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(2076, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(2076, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(2076, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(2076, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(2076, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(2076, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(2076, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(2076, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(2076, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(2076, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(2076, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2076, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(2076, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(2076, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(2076, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2076, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(2076, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(2076, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2076, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(2076, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2076, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(2076, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(2076, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(2076, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(2076, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(2076, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(2076, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2076, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(2076, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(2076, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(2076, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(2076, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(2076, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(2076, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(2076, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(2076, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(2076, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(2076, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(2076, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(2076, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(2076, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(2076, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(2076, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(2076, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(2076, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(2076, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2076, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(2076, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(2076, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(2076, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2076, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(2076, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(2076, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(2076, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(2076, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(2076, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(2076, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(2076, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(2076, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2076, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(2076, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2076, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(2076, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(2076, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2076, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(2076, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(2076, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(2076, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(2076, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(2076, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(2076, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(2076, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(2076, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(2076, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(2076, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(8271, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(8271, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(8271, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(8271, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(8271, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(8271, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(8271, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(8271, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(8271, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(8271, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(8271, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(8271, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(8271, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(8271, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(8271, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(8271, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(8271, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(8271, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(8271, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(8271, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(8271, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(8271, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8271, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(8271, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(8271, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(8271, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8271, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(8271, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(8271, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(8271, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(8271, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8271, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(8271, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(8271, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(8271, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(8271, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(8271, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(8271, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(8271, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(8271, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(8271, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(8271, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(8271, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(8271, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(8271, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8271, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(8271, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(8271, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(8271, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(8271, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(8271, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(8271, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(8271, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(8271, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(8271, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(8271, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(8271, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(8271, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(8271, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(8271, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(8271, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(8271, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(8271, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(8271, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(8271, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(8271, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(8271, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(8271, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8271, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(8271, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8271, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(8271, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(8271, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(8271, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(8271, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(8271, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(8271, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(8271, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(8271, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(8271, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(8271, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(8271, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(8271, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(8271, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(8271, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(8271, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(22340, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22340, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(22340, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22340, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(22340, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(22340, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(22340, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22340, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(22340, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22340, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22340, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22340, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(22340, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22340, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(22340, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(22340, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(22340, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22340, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(22340, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(22340, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22340, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(22340, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(22340, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(22340, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22340, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22340, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22340, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(22340, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22340, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(22340, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22340, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22340, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(22340, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22340, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(22340, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22340, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(22340, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(22340, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22340, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(22340, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22340, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(22340, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(22340, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(22340, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(22340, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22340, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(22340, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22340, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22340, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(22340, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(22340, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(22340, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22340, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22340, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22340, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22340, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(22340, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22340, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22340, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22340, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22340, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(22340, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22340, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22340, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(22340, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(22340, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(22340, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(22340, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(4593, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4593, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(4593, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4593, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(4593, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(4593, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(4593, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4593, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(4593, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(4593, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4593, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4593, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4593, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(4593, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4593, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(4593, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(4593, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(4593, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(4593, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4593, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(4593, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(4593, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4593, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(4593, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(4593, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(4593, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4593, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4593, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4593, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4593, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(4593, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4593, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(4593, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(4593, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(4593, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4593, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(4593, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(4593, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4593, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(4593, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4593, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4593, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(4593, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4593, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(4593, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4593, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4593, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(4593, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(4593, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(4593, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(4593, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4593, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(4593, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(4593, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(4593, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(4593, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4593, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4593, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(4593, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(4593, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(4593, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4593, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4593, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(4593, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4593, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(4593, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4593, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4593, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4593, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4593, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4593, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(4593, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(4593, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4593, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4593, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(4593, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(4593, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4593, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not coadminister aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [see Contraindications (4)].', 'DailyMed'),
(4593, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(4593, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4593, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(4593, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%.', 'DailyMed'),
(4593, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4)].', 'DailyMed'),
(4593, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', '•Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4)].', 'DailyMed'),
(4593, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', '• Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications (4 )].', 'DailyMed'),
(4593, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(4540, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4540, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(4540, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4540, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(4540, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(4540, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(4540, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4540, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(4540, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4540, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4540, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4540, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(4540, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4540, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(4540, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(4540, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(4540, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4540, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(4540, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(4540, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4540, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(4540, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(4540, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(4540, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(4540, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4540, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4540, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(4540, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4540, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(4540, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4540, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(4540, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(4540, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4540, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(4540, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(4540, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(4540, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(4540, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(4540, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(4540, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4540, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(4540, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(4540, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(4540, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(4540, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(4540, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(4540, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4540, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4540, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(4540, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(4540, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(4540, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4540, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4540, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(4540, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(4540, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(4540, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(4540, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(4540, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(4540, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4540, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(4540, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(4540, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(4540, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4540, 'tolterodine tartrate', 'N/A', 'minor', 'Diuretics Coadministration of tolterodine immediate release up to 8 mg (4 mg bid) for up to 12 weeks with diuretic agents, such as indapamide, hydrochlorothiazide, triamterene, bendroflumethiazide, chlorothiazide, methylchlorothiazide, or furosemide, did not cause any adverse electrocardiographic (ECG) effects.', 'DailyMed'),
(4540, 'phentermine and topiramate extended-release', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the Cmax and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed'),
(4540, 'topiramate spinkle', 'N/A', 'minor', '7.5 Hydrochlorothiazide (HCTZ) Topiramate Cmax and AUC increased when HCTZ was added to topiramate.', 'DailyMed'),
(4540, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. Levothyroxine Take at least 4 hours before Velphoro Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG‑CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin.', 'DailyMed'),
(22883, 'sotalol hydrochloride', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22883, 'bisoprolol fumarate and hydrochlorothiazide', 'N/A', 'moderate', 'Drug interactions Bisoprolol and hydrochlorothiazide may potentiate the action of other antihypertensive agents used concomitantly. Bisoprolol and hydrochlorothiazide should not be combined with other beta-blocking agents. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that bisoprolol and hydrochlorothiazide be discontinued for several days before the withdrawal of clonidine.Bisoprolol and hydrochlorothiazide should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists [particularly of the phenylalkylamine (verapamil) and benzothiazepine (diltiazem) classes], or antiarrhythmic agents, such as disopyramide, are used concurrently.', 'DailyMed'),
(22883, 'sotalol', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22883, 'hydrochlorothiazide', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.Alcohol, barbiturates, or narcoticsPotentiation of orthostatic hypotension may occur.Antidiabetic drugs - (oral agents and insulin)Dosage adjustment of the antidiabetic drug may be required.Other antihypertensive drugsAdditive effect or potentiation.Cholestryamine and colestipol resinsAbsorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.Corticosteroids, ACTHIntensified electrolyte depletion, particularly hypokalemia.Pressor amines (e.g., norepinephrine)Possible decreased r', 'DailyMed'),
(22883, 'lisinopril and hydrochlorothiazide', 'N/A', 'major', 'No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics.Alcohol, Barbiturates, Or Narcotics— potentiation of orthostatic hypotension may occur.Antidiabetic Drugs (Oral Agents And Insulin) — dosage adjustment of the antidiabetic drug may be required.Other Antihypertensive Drugs — additive effect or potentiation.Cholestyramine And Colestipol Resins — Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of ei', 'DailyMed'),
(22883, 'triamterene and hydrochlorothiazide', 'N/A', 'moderate', 'Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering nonsteroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.', 'DailyMed'),
(22883, 'doxazosin mesylate', 'N/A', 'minor', 'Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22883, 'benazepril hydrochloride', 'N/A', 'major', 'Other No clinically important pharmacokinetic interactions occurred when benazepril hydrochloride tablets were administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.', 'DailyMed'),
(22883, 'fosinopril sodium and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Potassium supplements and potassium-sparing diuretics: As noted above ("Derangements of Serum Electrolytes"), the net effect of fosinopril sodium and hydrochlorothiazide may be to elevate a patient''s serum potassium, to reduce it, or to leave it unchanged. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with fosinopril sodium and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Other ACE inhibitors have had less than additive effects with betaadrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.Interaction studies with warfarin have failed to identify any clinic', 'DailyMed'),
(22883, 'quinapril', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride andhydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22883, 'lisinopril', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22883, 'terazosin hydrochloride', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(22883, 'drug_class', 'N/A', 'minor', 'Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.', 'DailyMed'),
(22883, 'irbesartan and hydrochlorothiazide', 'N/A', 'minor', '[See Clinical Pharmacology (12.3).] Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22883, 'carvedilol phosphate', 'N/A', 'minor', 'Hydrochlorothiazide A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 patients with hypertension. Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol.', 'DailyMed'),
(22883, 'colestipol hydrochloride', 'N/A', 'major', 'The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride.', 'DailyMed'),
(22883, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(22883, 'etodolac', 'N/A', 'minor', 'Diuretics Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.', 'DailyMed'),
(22883, 'amantadine hydrochloride', 'N/A', 'minor', 'Coadministration of Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine 100 mg TID for Parkinson''s disease.1 It is not known which of the components of Dyazide contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22883, 'enalapril maleate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.', 'DailyMed'),
(22883, 'ketoprofen', 'N/A', 'minor', 'Hydrochlorothiazide, given concomitantly with ketoprofen, produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone.', 'DailyMed'),
(22883, 'febuxostat', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy subjects, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22883, 'pramipexole dihydrochloride', 'N/A', 'minor', 'Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.', 'DailyMed'),
(22883, 'losartan potassium and hydrochlorothiazide', 'N/A', 'minor', 'There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.', 'DailyMed'),
(22883, 'topiramate', 'N/A', 'minor', 'Hydrochlorothiazide (HCTZ): A drug-drug interaction study conducted in healthy volunteers evaluated the steady-state pharmacokinetics of HCTZ (25 mg q24h) and topiramate (96 mg q12h) when administered alone and concomitantly.', 'DailyMed'),
(22883, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22883, 'lisinopril, arginine', 'N/A', 'major', 'No clinically important pharmacokinetic interactions occurred when Lisinopril Tablets were used concomitantly with propranolol or hydrochlorothiazide.', 'DailyMed'),
(22883, 'losartan potassium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22883, 'milrinone lactate', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22883, 'irbesartan', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin. The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.', 'DailyMed'),
(22883, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'eprosartan mesylate and hydrochlorothiazide', 'N/A', 'minor', 'Or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics – potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins – Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Hydrochlorothiazide: When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or N arcotics - Potentiation of orthostatic hypotension may occur. Cholestyramine and Colestipol R esins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'amlodipine besylate and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22883, 'acebutolol hydrochloride', 'N/A', 'major', 'No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.', 'DailyMed'),
(22883, 'candesartan cilexetil and hydrochlorothiazide', 'N/A', 'major', 'Drug Interactions Candesartan Cilexetil No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers. Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics − Potentiation of orthostatic hypotension may occur. Cholestyramine and colestipol resins − Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(22883, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended. Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. Hydrochlorothiazide When administered concurrently, the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(22883, 'benazepril hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.', 'DailyMed'),
(22883, 'betaxolol', 'N/A', 'minor', 'Drug Interactions The following drugs have been coadministered with betaxolol and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.', 'DailyMed'),
(22883, 'fluconazole', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Triazolam Oral Contraceptives Pimozide Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association', 'DailyMed'),
(22883, 'fosinopril sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22883, 'candesartan cilexetil', 'N/A', 'major', '7 DRUG INTERACTIONS No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).', 'DailyMed'),
(22883, 'losartan potatssium', 'N/A', 'major', 'Drug Interactions No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.', 'DailyMed'),
(22883, 'terazosin', 'N/A', 'minor', 'Terazosin has been used concomitantly in at least 50 patients on the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole); 3) anticholinergic/sympathomimetics (e.g., phenylephrine hydrochloride, phenylpropanolamine hydrochloride, pseudoephedrine hydrochloride); 4) antigout (e.g., allopurinol); 5) antihistamines (e.g., chlorpheniramine); 6) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, methyclothiazide, propranolol); 7) corticosteroids; 8) gastrointestinal agents (e.g., antacids); 9) hypoglycemics; 10) sedatives and tranquilizers (e.g., diazepam).', 'DailyMed'),
(22883, 'carbamazepine', 'N/A', 'minor', 'Concomitant medication with carbamazepine and some diuretics (hydrochlorothiazide, furosemide) may lead to symptomatic hyponatremia.', 'DailyMed'),
(22883, 'quinapril hydrochloride', 'N/A', 'minor', 'No pharmacokinetic interaction was observed when single doses of quinapril hydrochloride and hydrochlorothiazide were administered concomitantly.', 'DailyMed'),
(22883, 'isradipine', 'N/A', 'minor', 'Nitroglycerin: A study in normal healthy volunteers has shown that concomitant administration of isradipine and hydrochlorothiazide does not result in altered pharmacokinetics of either drug. In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. Hydrochlorothiazide: In a single dose study in normal volunteers, co-administration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.', 'DailyMed'),
(22883, 'amlodipine and valsartan', 'N/A', 'major', 'Studies with Valsartan No clinically significant pharmacokinetic interactions were observed when valsartan was co-administered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22883, 'quinapril hydrochloride and hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium: Coadministration of quinapril HCl and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril HCl and hydrochlorothiazide tablets, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril HCl and hydrochlorothiazide tablets and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22883, 'memantine hydrochloride', 'N/A', 'minor', '7.4 Drugs Eliminated via Renal Mechanisms Because memantine is eliminated in part by tubular secretion, coadministration of drugs that use the same renal cationic system, including hydrochlorothiazide (HCTZ), triamterene (TA), metformin, cimetidine, ranitidine, quinidine, and nicotine, could potentially result in altered plasma levels of both agents.', 'DailyMed'),
(22883, 'pindolol', 'N/A', 'minor', 'Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.', 'DailyMed'),
(22883, 'diflunisal', 'N/A', 'major', 'In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide. Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.', 'DailyMed'),
(22883, 'moexipril hydrochloride', 'N/A', 'major', 'Other Agents No clinically important pharmacokinetic interactions occurred when moexipril hydrochloride was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.', 'DailyMed'),
(22883, 'doxazosin', 'N/A', 'minor', 'Doxazosin tablets have been used with the following drugs or drug classes: 1) analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin); 2) antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin); 3) antihistamines (e.g., chlorpheniramine); 4) cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol); 5) corticosteroids; 6) gastrointestinal agents (e.g., antacids); 7) hypoglycemics and endocrine drugs; 8) sedatives and tranquilizers (e.g., diazepam); 9) cold and flu remedies.', 'DailyMed'),
(22883, 'fluconazole, sodium chloride', 'N/A', 'contraindicated', 'These are described in greater detail below: Oral hypoglycemics Coumarin-type anticoagulants Phenytoin Cyclosporine Rifampin Theophylline Terfenadine Cisapride Astemizole Rifabutin Voriconazole Tacrolimus Short-acting benzodiazepines Tofacitinib Triazolam Oral Contraceptives Pimozide Quinidine Hydrochlorothiazide Alfentanil Amitriptyline, nortriptyline Amphotericin B Azithromycin Carbamazepine Calcium Channel Blockers Celecoxib Cyclophosphamide Fentanyl Halofantrine HMG-CoA reductase inhibitors Losartan Methadone Non-steroidal anti-inflammatory drugs Prednisone Saquinavir Sirolimus Vinca Alkaloids Vitamin A Zidovudine Oral hypoglycemics Clinically significant hypoglycemia may be precipitated by the use of fluconazole with oral hypoglycemic agents; one fatality has been reported from hypogl', 'DailyMed'),
(22883, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes [See Contraindications ( 4 )].', 'DailyMed'),
(22883, 'dofetilide', 'N/A', 'contraindicated', 'Hydrochlorothiazide (HCTZ) Alone or in Combination with Triamterene (see CONTRAINDICATIONS ) Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.', 'DailyMed'),
(22883, 'olmesartan medoxomil-hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS Lithium: Risk of lithium toxicity (7.2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) Antidiabetic drugs: Dosage adjustment may be required (7.6) Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increases in serum l', 'DailyMed'),
(22883, 'losartan pot/hctz', 'N/A', 'moderate', 'Monitor lithium levels in patients receiving losartan potassium and hydrochlorothiazide and lithium. Hydrochlorothiazide The administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when losartan potassium and hydrochlorothiazide and non-steroidal anti-inflammatory agents including selective COX-2 inhibitors are used concomitantly, observe closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22883, 'fosinopirl sodium', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22883, 'lithium carbonate', 'N/A', 'moderate', 'Reduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration (2.6), Warning and Precautions (5.3)] Examples: hydrochlorothiazide, chlorothiazide, furosemide Non-Steroidal Anti-inflammatory Drugs (NSAID) Clinical Impact: NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.', 'DailyMed'),
(22883, 'lisinopril and hydrochlorothiazide tablets', 'N/A', 'moderate', 'In general, avoid combined use of RAS inhibitors, closely monitor blood pressure, renal function and electrolytes in patients on lisinopril and hydrochlorothiazide tablets and other agents that affect the RAS. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide tablets in patients with diabetes. Avoid use of aliskiren with lisinopril and hydrochlorothiazide tablets in patients with renal impairment (GFR < 60 ml/min).', 'DailyMed'),
(22883, 'olmesartan medoxomil and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS • Lithium: Risk of lithium toxicity (7.2) • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic and antihypotensive effects; increased risk of renal toxicity (7.3) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.4) • Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7.5) • Antidiabetic drugs: Dosage adjustment may be required (7.6) • Cholestyramine and colestipol: Reduced absorption of thiazides (7.6) 7.1 Agents Increasing Serum Potassium Coadministration of olmesartan medoxomil and hydrochlorothiazide tablets with other drugs that raise serum potassium levels may result in hyperkalemia. 7.2 Lithium Increase', 'DailyMed'),
(22883, 'milrinone lactate in dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom Milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22883, 'metoprolol tartrate and hydrochlorothiazide', 'N/A', 'minor', 'Hydrochlorothiazide: Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). There have been rare reports in the literature of hemolytic anemia occurring with the concomitant use of hydrochlorothiazide and methyldopa. Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'fosinopril', 'N/A', 'minor', 'In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.', 'DailyMed'),
(22883, 'telmisartan and amlodipine', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(22883, 'amantadine', 'N/A', 'minor', 'Coadministration of triamterene and hydrochlorothiazide capsules resulted in a higher plasma amantadine concentration in a 61-year-old man receiving amantadine (hydrochloride capsules) 100 mg t.i.d. It is not known which of the components of triamterene and hydrochlorothiazide capsules contributed to the observation or if related drugs produce a similar response.', 'DailyMed'),
(22883, 'captopril and hydrochlorothiazide', 'N/A', 'moderate', 'Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including captopril and hydrochlorothiazide tablets. If a diuretic is also used, it may increase the risk of lithium toxicity (see PRECAUTIONS: Drug Interactions: Hydrochlorothiazide: Lithium ). Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur.', 'DailyMed'),
(22883, 'spironolactone and hydrochlorothiazide', 'N/A', 'moderate', 'Pressor Amines (e.g., norepinephrine) Both spironolactone and hydrochlorothiazide reduce the vascular responsiveness to norepinephrine. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with spironolactone and hydrochlorothiazide. Therefore, when spironolactone and hydrochlorothiazide tablets and NSAIDs are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.', 'DailyMed'),
(22883, 'milrinone lactate in 5% dextrose', 'N/A', 'minor', 'Drug Interactions No untoward clinical manifestations have been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements.', 'DailyMed'),
(22883, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 3 Drug Interactions with Hydrochlorothiazide When administered concurrently the following drugs may interact with thiazide diuretics: Antidiabetic Drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required. Cholestyramine and Colestipol Resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'valsartan/htcz', 'N/A', 'major', 'Valsartan-Hydrochlorothiazide: Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides. Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. Closely monitor blood pressure, renal function and electrolytes in patients on valsartan and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22883, 'amiloride hydrochloride and hydrochlorothiazide', 'N/A', 'minor', 'Therefore, when amiloride and hydrochlorothiazide plus non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Hydrochlorothiazide When given concurrently the following drugs may interact with thiazide diuretics. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.', 'DailyMed'),
(22883, 'febuxostat tablets 40 mg', 'N/A', 'major', '7.3 In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, febuxostat does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22883, 'dapagliflozin', 'N/A', 'minor', 'No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once dailyfor 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12%[↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7%[↓22%, ↑11%] ↓22%[↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of 500 mg followed by 14 doses of 250 mg every 6 hours) 10 mg ↑13%[↑3%, ↑24%] ↑51%[↑44%, ↑58%] ↔ = no change (geometric mean ratio of test: reference within 0.80 to 1.25); ↓ or ↑ = parameter was lower or higher, r', 'DailyMed'),
(22883, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan-Hydrochlorothiazide Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(22883, 'sotalol hydrochloride tables af', 'N/A', 'minor', 'Other No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.', 'DailyMed'),
(22883, 'quinapril hydrochloride/hydrochlorothiazide', 'N/A', 'moderate', 'Drug Interactions Agents Increasing Serum Potassium Coadministration of quinapril and hydrochlorothiazide with other drugs that raise serum potassium levels may result in hyperkalemia. Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with quinapril and hydrochlorothiazide, a thiazide diuretic is coadministered with the ACE inhibitor. Quinapril and hydrochlorothiazide and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended.', 'DailyMed'),
(22883, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(22883, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Valsartan – Hydrochlorothiazide Lithium: Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists or thiazides.', 'DailyMed'),
(22883, 'phentermine and topiramate', 'N/A', 'minor', 'Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively.', 'DailyMed');

